rs2789488

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001292034.3(TAB2):​c.1939+4970G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.446 in 151,936 control chromosomes in the GnomAD database, including 15,602 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 15602 hom., cov: 32)

Consequence

TAB2
NM_001292034.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.878

Publications

7 publications found
Variant links:
Genes affected
TAB2 (HGNC:17075): (TGF-beta activated kinase 1 (MAP3K7) binding protein 2) The protein encoded by this gene is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. This protein forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. This protein, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2). Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
TAB2 Gene-Disease associations (from GenCC):
  • chromosome 6q24-q25 deletion syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • congenital heart defects, multiple types, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • polyvalvular heart disease syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.585 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001292034.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAB2
NM_001292034.3
MANE Select
c.1939+4970G>A
intron
N/ANP_001278963.1
TAB2
NM_001369506.1
c.1939+4970G>A
intron
N/ANP_001356435.1
TAB2
NM_015093.6
c.1939+4970G>A
intron
N/ANP_055908.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TAB2
ENST00000637181.2
TSL:1 MANE Select
c.1939+4970G>A
intron
N/AENSP00000490618.1
TAB2
ENST00000470466.5
TSL:1
n.*538+4970G>A
intron
N/AENSP00000432709.1
TAB2
ENST00000367456.5
TSL:5
c.1939+4970G>A
intron
N/AENSP00000356426.1

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67653
AN:
151818
Hom.:
15580
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.546
Gnomad AMI
AF:
0.235
Gnomad AMR
AF:
0.455
Gnomad ASJ
AF:
0.420
Gnomad EAS
AF:
0.603
Gnomad SAS
AF:
0.502
Gnomad FIN
AF:
0.407
Gnomad MID
AF:
0.396
Gnomad NFE
AF:
0.377
Gnomad OTH
AF:
0.448
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.446
AC:
67726
AN:
151936
Hom.:
15602
Cov.:
32
AF XY:
0.448
AC XY:
33276
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.546
AC:
22611
AN:
41422
American (AMR)
AF:
0.455
AC:
6947
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.420
AC:
1455
AN:
3466
East Asian (EAS)
AF:
0.603
AC:
3111
AN:
5162
South Asian (SAS)
AF:
0.501
AC:
2415
AN:
4822
European-Finnish (FIN)
AF:
0.407
AC:
4276
AN:
10518
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.377
AC:
25623
AN:
67956
Other (OTH)
AF:
0.455
AC:
959
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1928
3855
5783
7710
9638
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.431
Hom.:
2334
Bravo
AF:
0.458
Asia WGS
AF:
0.602
AC:
2094
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.1
DANN
Benign
0.51
PhyloP100
-0.88
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2789488; hg19: chr6-149725290; API